| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3D DNM1L DEPDC1 SRGAP2 TBC1D3C TBC1D3B ASAP2 NF1 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 8.93e-12 | 279 | 118 | 16 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3D DNM1L DEPDC1 SRGAP2 TBC1D3C CHRM4 TBC1D3B RIC8B ASAP2 NF1 KIAA1755 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.41e-10 | 507 | 118 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3D DNM1L DEPDC1 SRGAP2 TBC1D3C CHRM4 TBC1D3B RIC8B ASAP2 NF1 KIAA1755 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.41e-10 | 507 | 118 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3D DNM1L DEPDC1 SRGAP2 TBC1D3C TBC1D3B STK3 ASAP2 NF1 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.13e-07 | 656 | 118 | 17 | GO:0008047 |
| GeneOntologyMolecularFunction | chromatin binding | RAG2 SOX15 SET SMARCA5 TOX POLR2A ASH1L NUP98 ADNP H1-8 TNRC18 POLR3D PSIP1 SETSIP ATXN7 SMARCA4 MLLT3 NIPBL | 3.38e-07 | 739 | 118 | 18 | GO:0003682 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E SET TBC1D3 TBC1D3H TBC1D3D DNM1L DEPDC1 SRGAP2 TBC1D3C CHRM4 TBC1D3B STK3 RIC8B ASAP2 NF1 PIK3R6 KIAA1755 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.60e-05 | 1418 | 118 | 22 | GO:0030234 |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E IL16 TBC1D3 TBC1D3H INCENP TBC1D3D DNM1L DEPDC1 SRGAP2 TBC1D3C TBC1D3B STK3 ASAP2 NF1 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.09e-04 | 1233 | 118 | 19 | GO:0140677 |
| GeneOntologyMolecularFunction | histone binding | 1.01e-03 | 265 | 118 | 7 | GO:0042393 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3D RAB11FIP2 SRGAP2 TBC1D3C TBC1D3B ASAP2 NF1 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 8.74e-12 | 244 | 117 | 15 | GO:0043547 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3D TBC1D3C TBC1D3B ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.92e-11 | 109 | 117 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3D RAB11FIP2 SRGAP2 TBC1D3C TBC1D3B ASAP2 NF1 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.48e-10 | 335 | 117 | 15 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3D RAB11FIP2 SRGAP2 IFI16 TBC1D3C TBC1D3B ASAP2 NF1 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.31e-08 | 499 | 117 | 16 | GO:0051345 |
| GeneOntologyBiologicalProcess | chromatin organization | USP36 RAG2 SOX15 SET SMARCA5 TOX ASH1L IFI16 H1-8 PSIP1 BRCA2 SETSIP CTR9 SMARCA4 MLLT3 PRKDC NIPBL | 1.21e-05 | 896 | 117 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3D RAB11FIP2 SRGAP2 IFI16 TBC1D3C TBC1D3B ASAP2 NF1 PIK3R6 CD74 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.93e-05 | 1028 | 117 | 18 | GO:0043085 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3D RAB11FIP2 SRGAP2 IFI16 TBC1D3C TBC1D3B ASAP2 NF1 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.64e-05 | 878 | 117 | 16 | GO:0051336 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | USP36 RAG2 SOX15 SET SMARCA5 TOX ASH1L IFI16 H1-8 PSIP1 BRCA2 SETSIP CTR9 SMARCA4 MLLT3 PRKDC NIPBL | 4.81e-05 | 999 | 117 | 17 | GO:0071824 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TBC1D3E TBC1D3 TBC1D3H TBC1D3D RAB11FIP2 SRGAP2 DHX33 IFI16 TBC1D3C TBC1D3B STK3 ASAP2 NF1 PIK3R6 SMARCA4 CD74 ARHGAP25 TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 4.98e-05 | 1430 | 117 | 21 | GO:0044093 |
| HumanPheno | Feeding difficulties | SOX11 SET TCF20 ACADS WFS1 PPFIBP1 POLR2A ASH1L DNM1L NUP214 ADNP ADARB1 NALCN ATXN7 PGAP1 KCNJ11 SMARCA4 NIPBL TOP3A | 9.48e-06 | 1168 | 32 | 19 | HP:0011968 |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.22e-11 | 49 | 112 | 9 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.57e-11 | 53 | 112 | 9 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.65e-11 | 55 | 112 | 9 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.65e-11 | 55 | 112 | 9 | IPR000195 |
| Domain | KRAB_RELATED | 1.89e-03 | 11 | 112 | 2 | PS50806 | |
| Domain | BAH | 1.89e-03 | 11 | 112 | 2 | SM00439 | |
| Domain | BAH | 1.89e-03 | 11 | 112 | 2 | PF01426 | |
| Domain | BAH | 1.89e-03 | 11 | 112 | 2 | PS51038 | |
| Domain | BAH_dom | 1.89e-03 | 11 | 112 | 2 | IPR001025 | |
| Domain | Rho_GTPase_activation_prot | 1.94e-03 | 88 | 112 | 4 | IPR008936 | |
| Domain | Krueppel-associated_box-rel | 2.66e-03 | 13 | 112 | 2 | IPR003655 | |
| Domain | WH2 | 3.09e-03 | 14 | 112 | 2 | SM00246 | |
| Domain | HMG_box | 3.95e-03 | 53 | 112 | 3 | PF00505 | |
| Domain | WH2 | 4.05e-03 | 16 | 112 | 2 | PF02205 | |
| Domain | HMG_BOX_2 | 4.17e-03 | 54 | 112 | 3 | PS50118 | |
| Domain | HMG | 4.17e-03 | 54 | 112 | 3 | SM00398 | |
| Domain | - | 4.39e-03 | 55 | 112 | 3 | 1.10.30.10 | |
| Domain | NAP | 4.57e-03 | 17 | 112 | 2 | PF00956 | |
| Domain | NAP_family | 4.57e-03 | 17 | 112 | 2 | IPR002164 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K | 8.49e-08 | 99 | 80 | 8 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.64e-24 | 11 | 119 | 10 | 16863688 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | USP36 SMARCA5 TCF20 POLR2A NUP98 NUP214 DHX33 SRBD1 ADNP IFI16 SLC25A3 UTP18 YAF2 WIZ PSIP1 CTR9 SMARCA4 PRKDC NIPBL ILVBL TOP3A | 2.94e-09 | 1294 | 119 | 21 | 30804502 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 6.84e-09 | 74 | 119 | 7 | 16625196 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SMARCA5 TCF20 POLR2A NUP98 NUP214 IFI16 ADARB1 UTP18 NF1 PSIP1 ATXN7 CTR9 SMARCA4 PRKDC NIPBL ANKS1A | 9.94e-09 | 774 | 119 | 16 | 15302935 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | USP36 SMARCA5 POLR2A NUP98 DNM1L TACC2 SRGAP2 NUP214 ADNP SLC25A3 WIZ PSIP1 SMARCA4 PRKDC NIPBL AHNAK2 ANKS1A | 2.14e-08 | 934 | 119 | 17 | 33916271 |
| Pubmed | USP36 SMARCA5 INCENP POLR2A NUP98 NUP214 DHX33 IFI16 STK3 UTP18 INF2 | 2.14e-08 | 332 | 119 | 11 | 25693804 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | USP36 SMARCA5 TCF20 INCENP POLR2A NUP214 DHX33 SEC31A SRBD1 ADNP IFI16 SLC25A3 UTP18 NF1 INF2 CTR9 SMARCA4 PRKDC NIPBL AHNAK2 | 3.44e-08 | 1353 | 119 | 20 | 29467282 |
| Pubmed | 7.88e-08 | 222 | 119 | 9 | 37071664 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.56e-07 | 4 | 119 | 3 | 12359748 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 8406013 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 15999204 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | USP36 SMARCA5 TCF20 INCENP POLR2A NUP98 NUP214 ADNP SLC25A3 PRAM1 WIZ PSIP1 BRCA2 SMARCA4 PRKDC NIPBL | 1.74e-07 | 954 | 119 | 16 | 36373674 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | POLR2A KSR2 SRGAP2 NUP214 PRAG1 CHRM4 TNRC18 WIZ INF2 PLEKHO2 CCDC34 KCNJ11 COBL CACNA1H PRKDC TOP3A AHNAK2 | 2.35e-07 | 1105 | 119 | 17 | 35748872 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | USP36 SET SMARCA5 INCENP POLR2A NUP98 DNM1L NUP214 SEC31A ADNP SLC25A3 RIC8B UTP18 NF1 PSIP1 CTR9 SMARCA4 PRKDC NIPBL | 3.84e-07 | 1425 | 119 | 19 | 30948266 |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 12604796 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 8471161 | ||
| Pubmed | SET SMARCA5 TRO ASH1L DACT2 NUP98 KRBA2 SRBD1 SH3D21 CCDC148 TNRC18 UTP18 PSIP1 SETSIP ATXN7 CTR9 FAM186A PRKDC NIPBL | 4.59e-07 | 1442 | 119 | 19 | 35575683 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.10e-07 | 283 | 119 | 9 | 30585729 | |
| Pubmed | 6.83e-07 | 210 | 119 | 8 | 16565220 | ||
| Pubmed | A putative 12 transmembrane domain cotransporter expressed in thymic cortical epithelial cells. | 7.75e-07 | 6 | 119 | 3 | 10706709 | |
| Pubmed | 1.35e-06 | 7 | 119 | 3 | 29959226 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.85e-06 | 167 | 119 | 7 | 20362541 | |
| Pubmed | SOX11 POLR2A DACT2 NUP214 SEC31A H1-8 WIZ BRCA2 SETSIP SMARCA4 COBL ILVBL ANKS1A | 2.00e-06 | 754 | 119 | 13 | 35906200 | |
| Pubmed | SET SMARCA5 TCF20 INCENP POLR2A NUP98 DNM1L ADNP IFI16 POLR3D PSIP1 CTR9 SMARCA4 PRKDC NIPBL | 2.07e-06 | 1014 | 119 | 15 | 32416067 | |
| Pubmed | SMARCA5 TCF20 INCENP POLR2A NUP98 NUP214 ADNP UTP18 NF1 SMARCA4 PRKDC NIPBL | 2.65e-06 | 653 | 119 | 12 | 22586326 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.58e-06 | 351 | 119 | 9 | 38297188 | |
| Pubmed | 4.61e-06 | 10 | 119 | 3 | 19082521 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TCF20 PPFIBP1 RAB11FIP2 DNM1L SRGAP2 PRAG1 CEP350 STK3 NF1 MTUS1 COBL AHNAK2 ANKS1A | 8.38e-06 | 861 | 119 | 13 | 36931259 |
| Pubmed | 8.40e-06 | 12 | 119 | 3 | 15140983 | ||
| Pubmed | 1.01e-05 | 83 | 119 | 5 | 28794006 | ||
| Pubmed | 1.01e-05 | 83 | 119 | 5 | 20562864 | ||
| Pubmed | Common type 2 diabetes risk gene variants associate with gestational diabetes. | 1.09e-05 | 13 | 119 | 3 | 18984664 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17296573 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17620317 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21720744 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 9126963 | ||
| Pubmed | Partial cloning of SOX-11 and SOX-12, two new human SOX genes. | 1.16e-05 | 2 | 119 | 2 | 8332506 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 35905214 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29273634 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19166587 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17525170 | ||
| Pubmed | Cardiovascular adaptations of pregnancy in T and B cell-deficient mice. | 1.16e-05 | 2 | 119 | 2 | 21613629 | |
| Pubmed | t(9;11)(p22;p15) with NUP98-LEDGF fusion gene in pediatric acute myeloid leukemia. | 1.16e-05 | 2 | 119 | 2 | 15725483 | |
| Pubmed | Dendritic cells require T cells for functional maturation in vivo. | 1.16e-05 | 2 | 119 | 2 | 10591187 | |
| Pubmed | BRCA2 Regulates Transcription Elongation by RNA Polymerase II to Prevent R-Loop Accumulation. | 1.16e-05 | 2 | 119 | 2 | 29386125 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23203926 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 1661315 | ||
| Pubmed | Effects of SET and SET-CAN on the differentiation of the human promonocytic cell line U937. | 1.16e-05 | 2 | 119 | 2 | 14671643 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22103895 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24449214 | ||
| Pubmed | Mammalian ISWI and SWI/SNF selectively mediate binding of distinct transcription factors. | 1.16e-05 | 2 | 119 | 2 | 30996347 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.35e-05 | 150 | 119 | 6 | 28242625 | |
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 1.46e-05 | 152 | 119 | 6 | 28192407 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.98e-05 | 332 | 119 | 8 | 32786267 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | TBC1D3H INCENP POLR2A DACT2 SEC31A CHRM4 SH3D21 RIC8B AUNIP MTUS1 | 2.12e-05 | 552 | 119 | 10 | 10737800 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.17e-05 | 440 | 119 | 9 | 34244565 | |
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 2.32e-05 | 165 | 119 | 6 | 16107646 | |
| Pubmed | 2.89e-05 | 103 | 119 | 5 | 32744500 | ||
| Pubmed | 3.07e-05 | 18 | 119 | 3 | 24025402 | ||
| Pubmed | 3.07e-05 | 18 | 119 | 3 | 33323119 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 3.32e-05 | 357 | 119 | 8 | 37059091 | |
| Pubmed | Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection. | 3.47e-05 | 3 | 119 | 2 | 22665378 | |
| Pubmed | Diversity of human copy number variation and multicopy genes. | 3.47e-05 | 3 | 119 | 2 | 21030649 | |
| Pubmed | ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia. | 3.47e-05 | 3 | 119 | 2 | 27154821 | |
| Pubmed | Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. | 3.47e-05 | 3 | 119 | 2 | 18538732 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 27197263 | ||
| Pubmed | Reversal of malignant ADAR1 splice isoform switching with Rebecsinib. | 3.47e-05 | 3 | 119 | 2 | 36803553 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 9847314 | ||
| Pubmed | An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2. | 3.47e-05 | 3 | 119 | 2 | 23349293 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 18299449 | ||
| Pubmed | Neurofibromatosis with male breast cancer--risk factor or co-incidence? Report of two rare cases. | 3.47e-05 | 3 | 119 | 2 | 25267367 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 8943370 | ||
| Pubmed | The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. | 3.47e-05 | 3 | 119 | 2 | 8885865 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 10545405 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 12559174 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 29594927 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 22937164 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 33804169 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 10843678 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 18096310 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 12589057 | ||
| Pubmed | V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. | 3.47e-05 | 3 | 119 | 2 | 8769647 | |
| Pubmed | B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destruction. | 3.47e-05 | 3 | 119 | 2 | 32938796 | |
| Pubmed | The nuclear pore complex: a new dynamic in HIV-1 replication. | 3.47e-05 | 3 | 119 | 2 | 21327100 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | USP36 SMARCA5 TCF20 INCENP POLR2A DHX33 SRBD1 ADNP SLC25A3 UTP18 CTR9 SMARCA4 PRKDC | 3.56e-05 | 989 | 119 | 13 | 36424410 |
| Pubmed | 4.01e-05 | 268 | 119 | 7 | 33640491 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SET INCENP POLR2A NUP98 TACC2 NUP214 MAD2L1BP CEP350 STK3 INF2 SMARCA4 PRKDC NIPBL TOP3A | 4.24e-05 | 1155 | 119 | 14 | 20360068 |
| Pubmed | 4.69e-05 | 486 | 119 | 9 | 20936779 | ||
| Pubmed | 4.97e-05 | 21 | 119 | 3 | 18591388 | ||
| Pubmed | Underlying genetic models of inheritance in established type 2 diabetes associations. | 4.97e-05 | 21 | 119 | 3 | 19602701 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SMARCA5 TCF20 POLR2A NUP98 NUP214 ADNP CEP350 SLC25A3 NF1 PSIP1 SMARCA4 PRKDC NIPBL | 5.08e-05 | 1024 | 119 | 13 | 24711643 |
| Pubmed | 6.58e-05 | 23 | 119 | 3 | 19720844 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 6.75e-05 | 123 | 119 | 5 | 26912792 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 15239126 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 25659033 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 23740949 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 10202929 | ||
| Pubmed | Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia. | 6.93e-05 | 4 | 119 | 2 | 25733518 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 23267015 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 9368759 | ||
| Interaction | CSNK2A1 interactions | SET IL16 POLR2A NUP98 IRF2 SRGAP2 SRBD1 ADNP IFI16 UTP18 YAF2 PSIP1 INF2 SETSIP CTR9 UBAC1 SMARCA4 ANKRD36 PRKDC | 1.66e-06 | 956 | 114 | 19 | int:CSNK2A1 |
| Interaction | SLX4 interactions | USP36 TCF20 INCENP POLR2A NUP214 ADNP CEP350 WIZ BRCA2 ATXN7 CTR9 SMARCA4 PRKDC NIPBL | 4.34e-06 | 572 | 114 | 14 | int:SLX4 |
| Interaction | XRCC6 interactions | USP36 SET SMARCA5 TCF20 DNM1L IRF2 ADNP IFI16 ADARB1 SLC25A3 TNRC18 YAF2 WIZ PSIP1 BRCA2 SMARCA4 PRKDC ILVBL | 4.53e-06 | 928 | 114 | 18 | int:XRCC6 |
| Interaction | H2AX interactions | SET SMARCA5 POLR2A ADNP IFI16 ADARB1 TNRC18 YAF2 WIZ PSIP1 BRCA2 SMARCA4 PRKDC NIPBL | 6.55e-06 | 593 | 114 | 14 | int:H2AX |
| Interaction | H2AZ1 interactions | USP36 SET SMARCA5 TCF20 INCENP SRBD1 ADNP WIZ PSIP1 SMARCA4 PRKDC | 8.40e-06 | 371 | 114 | 11 | int:H2AZ1 |
| Interaction | H2BC9 interactions | SMARCA5 TRO POLR2A ASH1L NUP98 CRAT ADARB1 CEP350 H1-8 TNRC18 PSIP1 ANKRD36 | 8.56e-06 | 446 | 114 | 12 | int:H2BC9 |
| Interaction | ZNF330 interactions | USP36 SET SMARCA5 TCF20 INCENP DHX33 SRBD1 WIZ PSIP1 CTR9 SMARCA4 NIPBL | 8.56e-06 | 446 | 114 | 12 | int:ZNF330 |
| Interaction | H2BC21 interactions | SMARCA5 TCF20 INCENP POLR2A SRBD1 ADNP IFI16 ADARB1 WIZ PSIP1 CTR9 SMARCA4 PRKDC NIPBL TOP3A | 8.93e-06 | 696 | 114 | 15 | int:H2BC21 |
| Interaction | H3C1 interactions | USP36 SOX11 SET SMARCA5 INCENP POLR2A ASH1L SRBD1 ADNP TNRC18 WIZ PSIP1 CTR9 SMARCA4 MLLT3 PRKDC NIPBL | 1.23e-05 | 901 | 114 | 17 | int:H3C1 |
| Interaction | NAA40 interactions | USP36 SMARCA5 POLR2A NUP98 DNM1L TACC2 SRGAP2 NUP214 ADNP SLC25A3 WIZ PSIP1 SMARCA4 PRKDC NIPBL AHNAK2 ANKS1A | 3.50e-05 | 978 | 114 | 17 | int:NAA40 |
| Interaction | TOP1 interactions | USP36 SOX15 SMARCA5 TCF20 POLR2A ADNP IFI16 SLC25A3 NF1 BRCA2 CTR9 SMARCA4 PRKDC NIPBL | 3.88e-05 | 696 | 114 | 14 | int:TOP1 |
| Interaction | PARP1 interactions | USP36 SMARCA5 INCENP POLR2A DNM1L IRF2 DHX33 SEC31A SRBD1 IFI16 ASAP2 UTP18 WIZ PSIP1 BRCA2 CTR9 SMARCA4 PRKDC NIPBL TOP3A | 4.53e-05 | 1316 | 114 | 20 | int:PARP1 |
| Interaction | TBXT interactions | 5.14e-05 | 116 | 114 | 6 | int:TBXT | |
| Interaction | NKX2-1 interactions | 7.43e-05 | 180 | 114 | 7 | int:NKX2-1 | |
| Interaction | FOXE1 interactions | 9.65e-05 | 81 | 114 | 5 | int:FOXE1 | |
| Interaction | POLR1G interactions | USP36 TCF20 INCENP POLR2A DHX33 POLR3D UTP18 WIZ CTR9 SMARCA4 NIPBL | 1.04e-04 | 489 | 114 | 11 | int:POLR1G |
| Interaction | HMGA1 interactions | SMARCA5 TCF20 POLR2A PANX2 TNRC18 PSIP1 BRCA2 CTR9 SMARCA4 PRKDC | 1.35e-04 | 419 | 114 | 10 | int:HMGA1 |
| Interaction | LLPH interactions | 1.40e-04 | 139 | 114 | 6 | int:LLPH | |
| Interaction | SMC5 interactions | USP36 SMARCA5 TCF20 INCENP POLR2A NUP98 NUP214 ADNP SLC25A3 PRAM1 WIZ PSIP1 BRCA2 SMARCA4 PRKDC NIPBL | 1.59e-04 | 1000 | 114 | 16 | int:SMC5 |
| Interaction | POLR1E interactions | 1.70e-04 | 350 | 114 | 9 | int:POLR1E | |
| Interaction | CIT interactions | SMARCA5 TCF20 INCENP POLR2A ASH1L NUP98 SEC31A SRBD1 ADNP IFI16 SLC25A3 UTP18 PSIP1 INF2 CTR9 SMARCA4 PRKDC NIPBL AHNAK2 DYRK3 | 1.71e-04 | 1450 | 114 | 20 | int:CIT |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.51e-12 | 149 | 119 | 10 | chr17q12 |
| Cytoband | 17q12 | 6.33e-06 | 99 | 119 | 5 | 17q12 | |
| Cytoband | 2p25 | 9.92e-04 | 18 | 119 | 2 | 2p25 | |
| Cytoband | 9q34.1 | 1.11e-03 | 19 | 119 | 2 | 9q34.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 2.14e-03 | 346 | 119 | 5 | chr17p13 | |
| GeneFamily | Ankyrin repeat domain containing | 1.15e-03 | 242 | 59 | 5 | 403 | |
| GeneFamily | SRY-boxes | 1.73e-03 | 19 | 59 | 2 | 757 | |
| GeneFamily | RNA polymerase subunits | 4.02e-03 | 29 | 59 | 2 | 726 | |
| GeneFamily | Nucleoporins | 4.88e-03 | 32 | 59 | 2 | 1051 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 2.89e-08 | 90 | 114 | 8 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | CELF6 TBC1D3 TBC1D3H TBC1D3D TBC1D3C TBC1D3B MTUS1 TBC1D3G TBC1D3K TBC1D3F | 7.41e-07 | 242 | 114 | 10 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3D TBC1D3C TBC1D3B CD74 CACNA1H TBC1D3G TBC1D3K TBC1D3F | 2.85e-06 | 281 | 114 | 10 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3D TBC1D3C TBC1D3B CD74 CACNA1H TBC1D3G TBC1D3K TBC1D3F | 2.85e-06 | 281 | 114 | 10 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 1.99e-05 | 213 | 114 | 8 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 1.99e-05 | 213 | 114 | 8 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | SOX11 TBC1D3 TBC1D3H TBC1D3D TRO RAB11FIP2 IFI16 TBC1D3C TBC1D3B SH3D21 STK3 TNRC18 ATXN7 PGAP1 CDC42EP5 CD74 CACNA1H ANKRD36 TBC1D3G TBC1D3K TBC1D3F | 3.15e-05 | 1466 | 114 | 21 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | CELF6 TBC1D3 TBC1D3H TBC1D3D PPFIBP1 TRO DACT2 SRGAP2 PTGES3L PRAG1 TBC1D3C TBC1D3B TNRC18 INF2 ATXN7 TBC1D3G TBC1D3K TBC1D3F | 4.17e-05 | 1153 | 114 | 18 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3D PRAG1 TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 5.81e-05 | 320 | 114 | 9 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | SOX11 TBC1D3 TBC1D3H TBC1D3D RAB11FIP2 TACC2 TBC1D3C TBC1D3B RIC8B ASAP2 CDC42EP5 CD74 CACNA1H ANKRD36 TBC1D3G TBC1D3K TBC1D3F | 5.95e-05 | 1075 | 114 | 17 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | FMO1 TBC1D3 TBC1D3H ACADS TBC1D3D CRAT TBC1D3C TBC1D3B SH3D21 CEP350 CDC42EP5 COBL CD74 TBC1D3G TBC1D3K TBC1D3F | 1.52e-04 | 1049 | 114 | 16 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.71e-04 | 369 | 114 | 9 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000 | CELF6 TBC1D3 TBC1D3H MORC4 TBC1D3C TBC1D3B SH3D21 CCDC148 PRAM1 TNRC18 YAF2 ZFP41 CDC42EP5 KIAA1755 TBC1D3F | 2.56e-04 | 986 | 114 | 15 | PCBC_ratio_ECTO_vs_SC_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.78e-04 | 311 | 114 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.06e-06 | 198 | 119 | 7 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.28e-06 | 151 | 119 | 6 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-06 | 179 | 119 | 6 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-06 | 179 | 119 | 6 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.12e-05 | 187 | 119 | 6 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 110 | 119 | 5 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.38e-05 | 194 | 119 | 6 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.38e-05 | 194 | 119 | 6 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 128 | 119 | 5 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 5.35e-05 | 151 | 119 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Batf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.43e-05 | 157 | 119 | 5 | 921805932f7974d37aed547861d555b07f30aba6 | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-05 | 157 | 119 | 5 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-05 | 157 | 119 | 5 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.14e-05 | 165 | 119 | 5 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.37e-05 | 166 | 119 | 5 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.61e-05 | 167 | 119 | 5 | 8a14fd980d8ebe8ef0216221f619d31aaa27ff15 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.37e-05 | 170 | 119 | 5 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 9.90e-05 | 172 | 119 | 5 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 172 | 119 | 5 | 95219814e37259e34be053572cc95d4639360c27 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 174 | 119 | 5 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 174 | 119 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 174 | 119 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 174 | 119 | 5 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 175 | 119 | 5 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.10e-04 | 176 | 119 | 5 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 176 | 119 | 5 | 8813c01ea080f373fe3970c5e1ba4c2dca0f7f02 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 176 | 119 | 5 | 87f90834c7278516beff7814b78f7c75732d9bf0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 177 | 119 | 5 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 177 | 119 | 5 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 1.13e-04 | 177 | 119 | 5 | 54f39be5d90363cfd44dea1a96ae06d3143aa795 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 177 | 119 | 5 | f6ff1b035fa2418f2448c99d81faa927ece93dfa | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 177 | 119 | 5 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 178 | 119 | 5 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.16e-04 | 178 | 119 | 5 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 179 | 119 | 5 | d0fa700648db8ce76a8aa689879a25048299fa40 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 179 | 119 | 5 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.19e-04 | 179 | 119 | 5 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 179 | 119 | 5 | 2e49b215b71438400aebb483f2c2c08d5e956961 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-04 | 181 | 119 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 184 | 119 | 5 | 1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 184 | 119 | 5 | 8578c50eaa8ce1cefc0228185c66c8e25f4bfc32 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.36e-04 | 184 | 119 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-04 | 185 | 119 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Mast_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.39e-04 | 185 | 119 | 5 | a6e5328801c233a44153420e2cdae644b253f540 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 185 | 119 | 5 | 9de1db2ce9e44956b1214daf6e1e161334679c88 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 185 | 119 | 5 | 18f5d9438c76e37988a7d17aa2a080af6bedbfc4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.46e-04 | 187 | 119 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.46e-04 | 187 | 119 | 5 | 2907cc0b8789c5e1468917caa21fa0feb025305e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.46e-04 | 187 | 119 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.46e-04 | 187 | 119 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.50e-04 | 188 | 119 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.54e-04 | 189 | 119 | 5 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.54e-04 | 189 | 119 | 5 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 189 | 119 | 5 | 16dfc37d8d390ed7f927bc844c47c9c5a89a0928 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.54e-04 | 189 | 119 | 5 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 189 | 119 | 5 | 3ade3fa9369e85304b20d7233b581f18ad5ecc89 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-04 | 190 | 119 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 190 | 119 | 5 | d4f954e0748898df69e1710df558564db703dd61 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-04 | 190 | 119 | 5 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.62e-04 | 191 | 119 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 191 | 119 | 5 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-04 | 191 | 119 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.65e-04 | 192 | 119 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.65e-04 | 192 | 119 | 5 | 5ef79faddb433c09ff36660d8bf7a3af5a67bf1d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-04 | 192 | 119 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-04 | 193 | 119 | 5 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-04 | 193 | 119 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-04 | 193 | 119 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 119 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 1.74e-04 | 194 | 119 | 5 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 1.74e-04 | 194 | 119 | 5 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.74e-04 | 194 | 119 | 5 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 119 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.78e-04 | 195 | 119 | 5 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 1.82e-04 | 196 | 119 | 5 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-04 | 197 | 119 | 5 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.86e-04 | 197 | 119 | 5 | dcce1c3dc5f3e53c368f758eb0fd5afcd86325e7 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-04 | 197 | 119 | 5 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.86e-04 | 197 | 119 | 5 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 197 | 119 | 5 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.86e-04 | 197 | 119 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | NS-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.91e-04 | 198 | 119 | 5 | e2acb074142aa62c763139bbcf36f6f85038d04b | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 198 | 119 | 5 | 54da18209ad67bf6b6b984786d95962fa90e6e8d | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.91e-04 | 198 | 119 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-04 | 198 | 119 | 5 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.91e-04 | 198 | 119 | 5 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-04 | 198 | 119 | 5 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.91e-04 | 198 | 119 | 5 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.91e-04 | 198 | 119 | 5 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.95e-04 | 199 | 119 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.95e-04 | 199 | 119 | 5 | 616c04b0605907fb218263f2164c36cb2fa26b87 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.00e-04 | 200 | 119 | 5 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-04 | 200 | 119 | 5 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 2.00e-04 | 200 | 119 | 5 | 9c2095dcf70f1288d55d0ff4a97efd4fd8d0c9ee | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative|Int-URO / Disease, condition lineage and cell class | 2.00e-04 | 200 | 119 | 5 | 99acc1ea01288efdd5b166aa20d66735f2bbe543 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.00e-04 | 200 | 119 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.00e-04 | 200 | 119 | 5 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.00e-04 | 200 | 119 | 5 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 6.18e-06 | 196 | 113 | 8 | 1082_UP | |
| Drug | Droperidol [548-73-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 6.42e-06 | 197 | 113 | 8 | 4629_UP | |
| Disease | diet measurement | BNC2 SLC4A8 TCF20 TOX RAB11FIP2 ADARB1 RIC8B NF1 NALCN INF2 SMARCA4 CACNA1H PRKDC NIPBL MYO16 | 5.89e-06 | 1049 | 107 | 15 | EFO_0008111 |
| Disease | severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, Nk cell-positive (implicated_via_orthology) | 1.30e-05 | 2 | 107 | 2 | DOID:0090013 (implicated_via_orthology) | |
| Disease | severe combined immunodeficiency (implicated_via_orthology) | 3.90e-05 | 3 | 107 | 2 | DOID:627 (implicated_via_orthology) | |
| Disease | pro‐interleukin‐16 measurement | 7.01e-04 | 11 | 107 | 2 | EFO_0010629 | |
| Disease | prediabetes syndrome (biomarker_via_orthology) | 8.40e-04 | 12 | 107 | 2 | DOID:11716 (biomarker_via_orthology) | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 9.52e-04 | 53 | 107 | 3 | C1961099 | |
| Disease | Coffin-Siris syndrome | 9.90e-04 | 13 | 107 | 2 | C0265338 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.13e-03 | 125 | 107 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.13e-03 | 125 | 107 | 4 | C1879321 | |
| Disease | Sarcoma, Spindle Cell | 1.15e-03 | 14 | 107 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 1.15e-03 | 14 | 107 | 2 | C0205944 | |
| Disease | cannabis dependence | 1.50e-03 | 135 | 107 | 4 | EFO_0007191 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.51e-03 | 16 | 107 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | squamous cell carcinoma | 1.88e-03 | 67 | 107 | 3 | EFO_0000707 | |
| Disease | CCL4 measurement | 2.37e-03 | 20 | 107 | 2 | EFO_0004751 | |
| Disease | Severe Combined Immunodeficiency | 2.37e-03 | 20 | 107 | 2 | C0085110 | |
| Disease | freckles | 2.37e-03 | 20 | 107 | 2 | EFO_0003963 | |
| Disease | Drugs used in diabetes use measurement | 2.41e-03 | 255 | 107 | 5 | EFO_0009924 | |
| Disease | non-small cell lung carcinoma | 2.59e-03 | 75 | 107 | 3 | EFO_0003060 | |
| Disease | Sarcoma | 2.62e-03 | 21 | 107 | 2 | C1261473 | |
| Disease | squamous cell lung carcinoma | 3.11e-03 | 165 | 107 | 4 | EFO_0000708 | |
| Disease | malignant astrocytoma (is_marker_for) | 3.14e-03 | 23 | 107 | 2 | DOID:3069 (is_marker_for) | |
| Disease | periodontal measurement | 3.41e-03 | 24 | 107 | 2 | EFO_0007780 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSPLMKQSVKKPPPG | 246 | P08173 | |
| SLKRQPKKPSQPKFM | 1336 | Q68DN1 | |
| KPLMLIAPKPQDKKS | 266 | Q9H2P0 | |
| PKRGRPKSKEMPQLE | 826 | Q9NR48 | |
| PKSKEMPQLEGPPKR | 831 | Q9NR48 | |
| LPKISPQKPPRKDME | 571 | Q8NFR7 | |
| RPQGMSKKPQKPKHS | 361 | A8MYA2 | |
| KSKPIPIMPASPQKG | 606 | O00429 | |
| PMPTPGLTLGKKEDK | 216 | P16219 | |
| DLAPKKKPRKSSMPV | 626 | Q6ZN30 | |
| PKPMSKEPKPDSNLL | 256 | P42568 | |
| PMPKKLRFNITPEIK | 376 | P43155 | |
| KAAMRRKDSPPPGKV | 531 | A6QL64 | |
| MIETKSSKPVPKPRV | 1081 | Q92625 | |
| KTLPGMNRPIQVKPA | 111 | Q96J87 | |
| PQRVLPLKKPPMKSL | 491 | P55895 | |
| KMPKRTKLLAQQPLP | 16 | Q96M98 | |
| MKQLPVLEPGDKPRK | 1 | Q7Z6M1 | |
| MLPLSERPSKKGKKP | 111 | P14316 | |
| SPLFRNPMSDPKKKE | 516 | P52948 | |
| PPPEMPESLKKKLGL | 346 | Q00325 | |
| LKIDPQMPAKKPKRG | 1491 | Q14667 | |
| KVPPKPDKAMRAPSS | 216 | Q8IZA3 | |
| PSPQAEEMLKKKPRA | 101 | Q15013 | |
| KEPELMPKTPSQKNR | 51 | Q9NQS7 | |
| MKTPPKGPSRKNLFT | 856 | Q9ULD2 | |
| PPPSPDSKKKSRGIM | 576 | Q86W92 | |
| STMKKIPPRKPKRSP | 1341 | Q9Y6X6 | |
| VKTKERNGRLPKPMP | 441 | Q5JYT7 | |
| PPAPMPRKSQATKLK | 931 | O43150 | |
| VTPPGTPPMRKKNKL | 271 | Q6VAB6 | |
| TPPMRKKNKLKPPGT | 276 | Q6VAB6 | |
| GPLRKRSVPMAKAKP | 366 | Q14654 | |
| QPRVMRPTKPKKTSA | 266 | Q9H0B8 | |
| EILVRKPMSSKPKPP | 586 | Q14005 | |
| PPPSLSEVARKMKKK | 1161 | Q6KC79 | |
| DKPTIKQPMLILRKP | 791 | Q5TB30 | |
| SLPKVPAKLSPMKQA | 931 | P35658 | |
| RKTPGPVLPKNALMQ | 71 | P78563 | |
| SVPSSPMSRKPQKLK | 661 | O15265 | |
| AKPKEPTMVAPRARK | 611 | Q27J81 | |
| TMDIKAPARPKTKPT | 1781 | Q9UMZ3 | |
| KEMVPAKPPKGLVGR | 221 | A1L0T0 | |
| PPKSKAEKIKRSPMD | 491 | Q5SW24 | |
| PIKKKELNSPQMTPF | 3311 | P51587 | |
| MPPPKEAKDLSGRKS | 326 | Q96HJ3 | |
| RVLKGVNKLPPPSVM | 391 | Q01740 | |
| VSVKSEMKKRRAPPP | 291 | O75128 | |
| KPERLPPSMKGKIKS | 996 | Q6PD62 | |
| KFPLTARVQKPDMKP | 356 | P56202 | |
| KLVKKILGPAPRMEP | 431 | Q5VT06 | |
| PLEPKFAKTILMSPK | 501 | Q9H6R0 | |
| PSHRMKKKGPSLPRG | 851 | Q9P2S6 | |
| PATLPRAKKMKGPIK | 46 | Q9BSJ5 | |
| RTGLPQGKKSPPHMK | 101 | Q6Q6R5 | |
| MPVLKQLGPAQPKKR | 1 | Q6NZY7 | |
| KTNPRNNDPKSMKLP | 391 | Q16666 | |
| ENLRMKLPKPPKPVS | 91 | P04233 | |
| KKPKVMVPPSSPQEL | 2086 | A6NE01 | |
| TATRPKKMGSQLPKP | 71 | Q969F0 | |
| GMKQKRKPASSEPTP | 26 | Q9Y5M1 | |
| EPALGARRKKKMSPP | 2176 | O95180 | |
| GMPPPKLLEQSKRAK | 426 | O43781 | |
| KPGTKMLTLLPGERK | 31 | Q9H7T9 | |
| KNPVPKRGLAPKPMT | 241 | Q6ZNG9 | |
| GAAEPPVVKRPRKKM | 416 | Q96RD6 | |
| KASKPLQMQIKAPPR | 456 | Q7Z2Y5 | |
| RKKPKMDPSAKPSAS | 121 | P35716 | |
| GAKPKRKPGMRPDWK | 16 | Q9Y5J1 | |
| KMKAPPKAARKTPGL | 231 | P05423 | |
| APIKEPKKLMPKTSL | 141 | A4FU49 | |
| LIDNRKVPLNPPGKM | 401 | Q9C0I9 | |
| KVPLNPPGKMKPSKE | 406 | Q9C0I9 | |
| AKPKEELLKPMGLKP | 481 | Q9NVN3 | |
| KAKPKPLLMPINTFS | 736 | Q5UE93 | |
| RKLPGKIDPSMLPAR | 436 | Q8TE76 | |
| PPMDPKLLKQLRKAE | 556 | Q96QH2 | |
| LSPNPPNLTKKMKKI | 1451 | P51532 | |
| KPIVLMKPREEGKGP | 96 | Q9H0W8 | |
| MAPKRQSPLPLQKKK | 11 | P0DME0 | |
| MAPKRQSPLPPQKKK | 1 | Q01105 | |
| SLPMQQPRKIKQKPT | 246 | Q11206 | |
| KRPSELPKDIKMISP | 716 | Q75T13 | |
| RKMFPGLAAPSLPKK | 1161 | O95785 | |
| KNVPSQEKRKMPGVP | 411 | Q2Y0W8 | |
| PKRMPRVKKNAPQIS | 61 | Q8N5C6 | |
| GHLPKVQRPSLKMPK | 756 | Q8IVF2 | |
| LPKLQMPSFKVPKVD | 1411 | Q8IVF2 | |
| LPKLQMPSFKVPKVD | 2236 | Q8IVF2 | |
| MPSLKTPKVDLKGPQ | 3561 | Q8IVF2 | |
| LPKLQMPSFKVPKVD | 4381 | Q8IVF2 | |
| TEVKIPKPRGRPKMV | 186 | O75475 | |
| SMKKLTRKQGDLPPP | 346 | A6NDS4 | |
| SMKKLTRKQGDLPPP | 346 | P0C7X1 | |
| PLITMPATRPKPKKA | 2426 | O15417 | |
| PGTLPLEKVKRPMNA | 41 | O60248 | |
| MEQPPAPKSKLKKLS | 1 | Q13188 | |
| MEKPAGRKKKTPTPR | 1 | Q8N8Y5 | |
| LAMDPPVVNRPKKSK | 56 | Q12816 | |
| SMKKLTRKKGDVPPP | 346 | A6NER0 | |
| RIFPKIMPKKPAEEG | 106 | Q7RTT5 | |
| RIIPKIMPKKPAEEG | 106 | Q7RTT4 | |
| PNPLERPIKMGWLKK | 41 | P42331 | |
| PRAMQKSGRPLKSLK | 326 | P24928 | |
| KSVKMAAPVKPPATR | 1026 | O75044 | |
| MGDKKSPTRPKRQPK | 1 | Q8IY57 | |
| PPPRIERGLKLMSKI | 1431 | P21359 | |
| RPKMKKTPEKLDNTP | 2301 | O95359 | |
| SMKKLTRKKGDLPPP | 346 | A0A087X179 | |
| QMKSKPKKPFLLGPQ | 206 | Q7L804 | |
| NPPPKRATEMQSKVK | 1736 | Q9UGU0 | |
| PPPKSRHLLKMNKSS | 716 | Q86YV5 | |
| LKLKFKRGSLPPTMP | 716 | Q13472 | |
| LLLKMNKDSKPPGNL | 3666 | P78527 | |
| QRSLPVKPSKMLKPS | 661 | Q6R2W3 | |
| TPPPKILSEKLKASM | 311 | Q8TD55 | |
| SMKKLTRKQGDLPPP | 346 | A0A087WVF3 | |
| LIKKRAPSPLPKMAD | 91 | Q9BSL1 | |
| ELLKKVSTKRPPPAM | 136 | E9PB15 | |
| QKTPTSPLKMKPGRP | 111 | O60264 | |
| SPLKMKPGRPRIKKD | 116 | O60264 | |
| NDPPALNRVPKKKKM | 996 | O94979 | |
| SMKKLTRKQGDLPPP | 346 | Q6DHY5 | |
| SMKKLTRKKGDLPPP | 346 | Q8IZP1 | |
| EKRPASDMGKKPKTP | 236 | O94900 | |
| TVMKGDPKALRPKPT | 206 | A6NGD5 | |
| SMKKLTRKKGDLPPP | 346 | A0A087X1G2 | |
| MSPPPAKKLALSAKK | 681 | Q9P275 | |
| SMKKLTRKQGDLPPP | 346 | A0A087WXS9 | |
| SMKKLTRKKGDLPPP | 346 | Q6IPX1 | |
| PGPVPKSLQKQRRML | 216 | O76024 | |
| KFPNRPQMVKISKLP | 636 | Q8IZF0 |